Analyzing the Risks and Benefits of Dual Use Biotechnology

LEAP Alumnus Ryan Ritterson joined Gryphon Scientific, which provides data-driven and scientific analysis for infectious disease, biosafety, biosecurity, and other global policy challenges. Ryan served as a lead analyst on the Risk and Benefit Analysis of Gain-of-Function Research commissioned by the US National Scientific Advisory Board for Biosecurity (NSABB), including developing a comprehensive quantitative framework for analyzing the biosafety risk of virological research. Ryan has since led and contributed to multiple projects related to safety, security and strategy in the development of advanced biotechnologies.